Table 2

Verification cohort clinicopathological characteristics

Verification phaseSingaporeanKorean
Case–control cohortCase–control cohort
Subjects cohort sizeControl subjects
n=69
Patients with cancer
n=20
Control subjects
n=47
Patients with cancer
n=74
GenderMale32 (46.4%)14 (70.0%)35 (74.5%)44 (59.5%)
Female37 (53.6%)6 (30.0%)12 (25.5%)30 (40.5%)
Age63.3±8.4 (SD)74.8±9.5 (SD)26.4±2.7 (SD)59.1±10.6 (SD)
EthnicityChinese (%)69 (100%)20 (100%)
Korean (%)47 (100%)74 (100%)
Stages (AJCC 2010)Stage 0 (%)
Stage 1 (%)10 (50.0%)17 (23.0%)
Stage 2 (%)3 (15.0%)21 (28.4%)
Stage 3 (%)6 (30.0%)17 (23.0%)
Stage 4 (%)1 (5.0%)19 (25.7%)
Unknown (%)
Histological subtypeIntestinal35 (47.3%)
Diffuse31 (41.9%)
Mixed0 (0.0%)
Unknown8 (10.8%)
GastritisNo0 (0%)0 (0%)
Yes69 (100%)12 (60%)
Unknown8 (40%)
Intestinal metaplasiaNo17 (24.6%)0 (0.0%)
Yes52 (75.4%)10 (50.0%)
Unknown10 (50.0%)
AtrophyNo32 (46.4%)0 (0.0%)
Yes37 (53.6%)1 (5.0%)
Unknown19 (95.0%)
H PyloriNo18 (26.1%)2 (10.0%)
Yes51 (73.9%)18 (90.0%)